RESEARCHER PROFILE

Herbert Y. Meltzer

← Back to Northwestern University

H

Northwestern University

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorTreatment of Major DepressionNeuroscience and Neuropharmacology ResearchMental Health and Psychiatry

Herbert Y. Meltzer works in Schizophrenia research and treatment, Neurotransmitter Receptor Influence on Behavior, Treatment of Major Depression, Neuroscience and Neuropharmacology Research, Mental Health and Psychiatry. Recorded institutional associations include Northwestern University, Northwestern University.

1,075Publications
61,516Citations
119H-index

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗∗See accompanying Editorial, in this issue.

    1999 · 1,475 citations

  2. Clozapine Treatment for Suicidality in Schizophrenia International Suicide Prevention Trial (InterSePT)

    2003 · 1,390 citations

  3. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.

    1989 · 1,349 citations

  4. Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III

    2005 · 1,140 citations

  5. Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

    2016 · 1,132 citations

  6. H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs

    2003 · 801 citations

  7. Serotonin receptors : their key role in drugs to treat schizophrenia

    2003 · 775 citations

  8. Cellular changes in the postmortem hippocampus in major depression

    2004 · 732 citations

  9. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression

    1995 · 627 citations

  10. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia

    2005 · 605 citations

  11. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

    1989 · 602 citations

  12. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors

    2019 · 592 citations

  13. 5‐HT2A and D2 receptor blockade increases cortical DA release via 5‐HT1A receptor activation: a possible mechanism of atypical antipsychotic‐induced cortical dopamine release

    2001 · 494 citations

  14. Treatment-Resistant Schizophrenia - The Role of Clozapine

    1997 · 491 citations

  15. Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial

    2006 · 472 citations

  16. Lowered ω3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients

    1999 · 453 citations

  17. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: The MIND randomized, placebo-controlled trial*

    2010 · 451 citations

  18. A Genome-Wide Investigation of SNPs and CNVs in Schizophrenia

    2009 · 447 citations

  19. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression

    1993 · 439 citations

  20. Increased Depressive Ratings in Patients With Hepatitis C Receiving Interferon-α–Based Immunotherapy Are Related to Interferon-α–Induced Changes in the Serotonergic System

    2002 · 437 citations

  21. Update on Typical and Atypical Antipsychotic Drugs

    2012 · 433 citations

  22. Fatty acid composition in major depression: decreased ω3 fractions in cholesteryl esters and increased C20:4ω6C20:5ω3 ratio in cholesteryl esters and phospholipids

    1996 · 417 citations

  23. Identification of vascular structures as a major source of signal contrast in high resolution 2D and 3D functional activation imaging of the motor cortex at l.5T preliminary results

    1993 · 390 citations

  24. Cloning, Characterization, and Chromosomal Localization of a Human 5‐HT6 Serotonin Receptor

    1996 · 377 citations

  25. Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?

    1993 · 364 citations

← Return to the university profile